Several studies have identified over-representation of HLA-DPB1*0501, HLA-DRB1*0301, or HLA-DRB3 in NMO patients,22–24 suggesting that these MHC II alleles could serve as restriction elements for CD4+ T cells in NMO. This evidence concerns the gene CD4 and neuromyelitis optica.